Targeting Gαi2 in neutrophils protects from myocardial ischemia reperfusion injury
Basic Research in Cardiology · 30.05.2024 · 119 (5) · 717-732
DOI: 10.1007/s00395-024-01057-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic Research in Cardiology, online erschienen am 30.05.2024. Verfasst von David Köhler und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care Medicine, Eberhard Karls University, Tübingen, Germany. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Neutrophils, GTP-Binding Protein alpha Subunit, Gi2, Mice, Knockout. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Medical Faculty Eberhard-Karls-University Tübingen, Medizinische Fakultät, Universität Tübingen.
Abstract (Originalsprache)
Neutrophils are not only involved in immune defense against infection but also contribute to the exacerbation of tissue damage after ischemia and reperfusion. We have previously shown that genetic ablation of regulatory Gα i proteins in mice has both protective and deleterious effects on myocardial ischemia reperfusion injury (mIRI), depending on which isoform is deleted. To deepen and analyze these findings in more detail the contribution of Gα i2 proteins in resident cardiac vs circulating blood cells for mIRI was first studied in bone marrow chimeras. In fact, the absence of Gα i2 in all blood cells reduced the extent of mIRI (22,9% infarct size of area at risk (AAR) Gnai2 −/− → wt vs 44.0% wt → wt; p < 0.001) whereas the absence of Gα i2 in non-hematopoietic cells increased the infarct damage (66.5% wt → Gnai2 −/− vs 44.0% wt → wt; p < 0.001). Previously we have reported the impact of platelet Gα i2 for mIRI. Here, we show that infarct size was substantially reduced when Gα i2 signaling was either genetically ablated in neutrophils/macrophages using LysM-driven Cre recombinase (AAR: 17.9% Gnai2 fl/fl LysM-Cre + /tg vs 42.0% Gnai2 fl/fl ; p < 0.01) or selectively blocked with specific antibodies directed against Gα i2 (AAR: 19.0% (anti-Gα i2 ) vs 49.0% (IgG); p < 0.001). In addition, the number of platelet-neutrophil complexes (PNCs) in the infarcted area were reduced in both, genetically modified (PNCs: 18 ( Gnai2 fl/fl ; LysM-Cre + /tg ) vs 31 ( Gnai2 fl/fl ); p < 0.001) and in anti-Gα i2 antibody-treated (PNCs: 9 (anti-Gα i2 ) vs 33 (IgG); p < 0.001) mice. Of note, significant infarct-limiting effects were achieved with a single anti-Gα i2 antibody challenge immediately prior to vessel reperfusion without affecting bleeding time, heart rate or cellular distribution of neutrophils. Finally, anti-Gα i2 antibody treatment also inhibited transendothelial migration of human neutrophils (25,885 (IgG) vs 13,225 (anti-Gα i2 ) neutrophils; p < 0.001), collectively suggesting that a therapeutic concept of functional Gα i2 inhibition during thrombolysis and reperfusion in patients with myocardial infarction should be further considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Intensive Care Medicine, Eberhard Karls University, Tübingen, Germany.
- Department of Pharmacology, Experimental Therapy and Toxicology, Institute for Experimental and Clinical Pharmacology and Pharmacogenomic, Eberhard Karls University, and Interfaculty Center of Pharmacogenomic and Drug R…
- Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
- Division of Dermatooncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany.
- Department of Biology, Indian Institute of Science Education and Research (IISER) Tirupati, Tirupati, 517507, India.
- Department of Preclinical Imaging and Radiopharmacy, Multiscale Immunoimaging, Eberhard Karls University, Tübingen, Germany.
ORCID-Profile: Sandra Beer-Hammer
Förderung
- Deutsche Forschungsgemeinschaft
- Medical Faculty Eberhard-Karls-University Tübingen
- Medizinische Fakultät, Universität Tübingen
- Universitätsklinikum Tübingen
Zitieren
APA
Köhler, D., Leiss, V., Beichert, L., Killinger, S., Grothe, D., Kushwaha, R., Schröter, A., Roslan, A., Eggstein, C., Focken, J., Granja, T., Devanathan, V., Schittek, B., Lukowski, R., Weigelin, B., Rosenberger, P., Nürnberg, B., & Beer-Hammer, S. (2024). Targeting Gαi2 in neutrophils protects from myocardial ischemia reperfusion injury. Basic Research in Cardiology, 119(5), 717-732. https://doi.org/10.1007/s00395-024-01057-x
Vancouver
Köhler D, Leiss V, Beichert L, Killinger S, Grothe D, Kushwaha R, et al. Targeting Gαi2 in neutrophils protects from myocardial ischemia reperfusion injury. Basic Research in Cardiology. 2024;119(5):717-732. doi:10.1007/s00395-024-01057-x
BibTeX
@article{Khler2024,
author = {Köhler, David and Leiss, Veronika and Beichert, Lukas and Killinger, Simon and Grothe, Daniela and Kushwaha, Ragini and Schröter, Agnes and Roslan, Anna and Eggstein, Claudia and Focken, Jule and Granja, Tiago and Devanathan, Vasudharani and Schittek, Birgit and Lukowski, Robert and Weigelin, Bettina and Rosenberger, Peter and Nürnberg, Bernd and Beer-Hammer, Sandra},
title = {Targeting Gαi2 in neutrophils protects from myocardial ischemia reperfusion injury},
journal = {Basic Research in Cardiology},
year = {2024},
volume = {119},
number = {5},
pages = {717--732},
doi = {10.1007/s00395-024-01057-x}
}
EUVIMED